Chronic TGF-β exposure drives stabilized EMT, tumor stemness, and cancer drug resistance with vulnerability to bitopic mTOR inhibition

Yoko Katsuno; Dominique Stephan Meyer; Ziyang Zhang; Kevan M. Shokat; Rosemary J. Akhurst; Kohei Miyazono; Rik Derynck

doi:10.1126/scisignal.aau8544

Research ArticleCancer

Chronic TGF-β exposure drives stabilized EMT, tumor stemness, and cancer drug resistance with vulnerability to bitopic mTOR inhibition

View ORCID ProfileYoko Katsuno ¹,²,³,
View ORCID ProfileDominique Stephan Meyer ⁴,
View ORCID ProfileZiyang Zhang⁵,
View ORCID ProfileKevan M. Shokat ⁵,
View ORCID ProfileRosemary J. Akhurst ²,⁴,⁶,
View ORCID ProfileKohei Miyazono ³, and
View ORCID ProfileRik Derynck ¹,²,⁴,⁶,*

¹Department of Cell and Tissue Biology, University of California at San Francisco, San Francisco, CA 94143, USA.
²Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California at San Francisco, San Francisco, CA 94143, USA.
³Department of Molecular Pathology, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan.
⁴Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, CA 94143, USA.
⁵Department of Cellular and Molecular Pharmacology and Howard Hughes Medical Institute, University of California at San Francisco, San Francisco, CA 94143, USA.
⁶Department of Anatomy, University of California at San Francisco, San Francisco, CA 94143, USA.

↵*Corresponding author. Email: rik.derynck{at}ucsf.edu

See allHide authors and affiliations

Science Signaling 26 Feb 2019:
Vol. 12, Issue 570, eaau8544
DOI: 10.1126/scisignal.aau8544

Yoko Katsuno

1Department of Cell and Tissue Biology, University of California at San Francisco, San Francisco, CA 94143, USA.

2Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California at San Francisco, San Francisco, CA 94143, USA.

3Department of Molecular Pathology, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Yoko Katsuno

Dominique Stephan Meyer

4Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, CA 94143, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Dominique Stephan Meyer

Ziyang Zhang

5Department of Cellular and Molecular Pharmacology and Howard Hughes Medical Institute, University of California at San Francisco, San Francisco, CA 94143, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Ziyang Zhang

Kevan M. Shokat

5Department of Cellular and Molecular Pharmacology and Howard Hughes Medical Institute, University of California at San Francisco, San Francisco, CA 94143, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Kevan M. Shokat

Rosemary J. Akhurst

2Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California at San Francisco, San Francisco, CA 94143, USA.

4Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, CA 94143, USA.

6Department of Anatomy, University of California at San Francisco, San Francisco, CA 94143, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Rosemary J. Akhurst

Kohei Miyazono

3Department of Molecular Pathology, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Kohei Miyazono

Rik Derynck

1Department of Cell and Tissue Biology, University of California at San Francisco, San Francisco, CA 94143, USA.

2Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California at San Francisco, San Francisco, CA 94143, USA.

4Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, CA 94143, USA.

6Department of Anatomy, University of California at San Francisco, San Francisco, CA 94143, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Rik Derynck
For correspondence: rik.derynck@ucsf.edu

Article
Figures & Data
Info & Metrics
eLetters
PDF

Article Information

vol. 12 no. 570

DOI:

https://doi.org/10.1126/scisignal.aau8544

PubMed:

Published By:

Print ISSN:

Online ISSN:

History:

Received July 21, 2018
Accepted January 28, 2019
.

Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works http://www.sciencemag.org/about/science-licenses-journal-article-reuseThis is an article distributed under the terms of the Science Journals Default License.

Author Information

Altmetric

Article usage

Article usage: February 2019 to August 2020

	Abstract	Full	Pdf
Feb 2019	148	3852	743
Mar 2019	490	3995	1064
Apr 2019	271	201	116
May 2019	253	300	78
Jun 2019	274	102	63
Jul 2019	186	79	66
Aug 2019	156	58	36
Sep 2019	119	64	32
Oct 2019	151	56	54
Nov 2019	121	46	36
Dec 2019	108	38	19
Jan 2020	148	75	40
Feb 2020	83	48	23
Mar 2020	4	167	72
Apr 2020	18	151	68
May 2020	14	252	118
Jun 2020	21	171	53
Jul 2020	11	129	38
Aug 2020	7	40	15

View Full Text

Chronic TGF-β exposure drives stabilized EMT, tumor stemness, and cancer drug resistance with vulnerability to bitopic mTOR inhibition

Article Information

Author Information

Altmetric

Article usage

Article usage: February 2019 to August 2020

Science Signaling

Article Tools